share_log

LARKSPUR HEALTH ACQUISITION CORP C/WTS (TO PUR COM) | 8-K: ZyVersa Therapeutics Reports First Quarter 2023 Corporate and Financial Results Key Highlights:

SEC ·  May 13, 2023 09:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more